Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Outset Medical Inc. (OM:NASDAQ), powered by AI.
Outset Medical Inc. is currently trading at $4.41. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Outset Medical Inc. on Alpha Lenz.
Outset Medical Inc.'s P/E ratio is -0.8.
“Outset Medical Inc. trades at a P/E of -0.8 (undervalued) with modest ROE of -106.2%.”
Ask for details →Outset Medical Inc. is a pioneering company in the medical technology field, primarily focusing on the development and commercialization of innovative dialysis solutions. Its flagship product, the Tablo Hemodialysis System, is designed to simplify dialysis treatments, whether in medical facilities or at home. The system integrates water purification with dialysate production, offering a seamless, all-in-one dialysis solution. This transformative approach aims to make dialysis more accessible and user-friendly for patients and healthcare providers. Outset Medical's advancements in the dialysis sector are significant, as they strive to redefine treatment standards and improve patient quality of life. Headquartered in the United States, Outset Medical continues to impact the healthcare industry by addressing the growing demand for efficient and scalable renal care solutions.
“Outset Medical Inc. trades at a P/E of -0.8 (undervalued) with modest ROE of -106.2%.”
Ask for details →Outset Medical Inc. (ticker: OM) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 354 employees. Market cap is $67M.
The current price is $4.41 with a P/E ratio of -0.82x and P/B of 0.53x.
ROE is -106.20% and operating margin is -55.83%. Annual revenue is $119M.